Determine relative & absolute KiNativ™ IC50/Kd values to accurately assess off-target risks
- High correlation between KiNativ™ results and in vivo efficacy enables an elevated level of decision making compared to recombinant kinase assays
- Eliminate wasted efforts on false positives (both on- or off-target hits)
Generate SAR for all kinases found in your cellular or animal efficacy model
- Focus on the kinases that really matter in your system
- Directly correlate target binding with biological outcome to confirm mechanism of action
Ex vivo profiling of treated live
cells or tissues from treated animals
- Verify target engagement in tissue of interest (pharmacodynamic studies)
- Determine mechanism of action and/or toxicity
- Identify primary and secondary effects of compound treatment
- Discover clinical biomarkers from biopsy or blood samples